Article metrics

Download PDFPDF

203 Preclinical characterization and development of MG1124, a Novel Immune Checkpoint inhibitor targeting CEACAM1 for NSCLC patients

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020214024
Dec 202042018
Jan 20211705
Feb 20211404
Mar 20213406
Apr 20212204
May 2021204
Jun 2021003
Jul 2021003
Aug 2021005
Sep 2021006
Oct 202120032
Nov 202128014
Dec 202154021
Jan 20222606
Feb 20223005
Mar 20224009
Apr 20223809
May 20224004
Jun 20223205
Jul 20221803
Aug 20223004
Sep 20223403
Oct 20225208
Nov 20223208
Dec 20221800
Jan 20231201
Feb 202366012
Mar 202332010
Apr 202320012
May 20233406
Jun 20232404
Jul 20232408
Aug 20231001
Sep 20236006
Oct 20234006
Nov 20232802
Dec 20232602
Jan 20241600
Feb 20241200
Mar 20243403
Apr 20241403
May 20242603
Jun 20242602
Jul 20241601
Aug 20241602
Sep 20243605
Oct 20241207
Nov 20241203
Dec 202422010
Jan 20252807
Feb 2025403
Mar 2025005
Apr 20250011
May 2025005
Jun 2025007
Total14870360